Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant genes (Expand Search)
green decrease » greater decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
Showing 1,021 - 1,040 results of 21,342 for search '(( significant decrease decrease ) OR ( significant green decrease ))', query time: 0.55s Refine Results
  1. 1021
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1022
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1023
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1024
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1025
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1026
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1027
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  8. 1028
    Effects of BM-MSCs on ROS generation in DCS rats.

    Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1029
    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation.

    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1030
    Isotype control overlays.

    Isotype control overlays. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1031
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1032
    Original uncropped blot.

    Original uncropped blot. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1033
    Characterization of BM-MSC.

    Characterization of BM-MSC. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1034
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1035
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1036
    The ANCOVA and Post_hoc results.

    The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1037
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1038
    Identification of BM-MSCs.

    Identification of BM-MSCs. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1039
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1040
    Effect of BM-MSCs in improving DCS induced lung injury.

    Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: